Billecke S

References (8)

Title : Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals - La_2001_Drug.Metab.Dispos_29_566
Author(s) : La Du BN , Billecke S , Hsu C , Haley RW , Broomfield CA
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 29 :566 , 2001
Abstract : La_2001_Drug.Metab.Dispos_29_566
ESTHER : La_2001_Drug.Metab.Dispos_29_566
PubMedSearch : La_2001_Drug.Metab.Dispos_29_566
PubMedID: 11259353

Title : Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants - Aviram_1999_Free.Radic.Biol.Med_26_892
Author(s) : Aviram M , Rosenblat M , Billecke S , Erogul J , Sorenson R , Bisgaier CL , Newton RS , La Du BN
Ref : Free Radic Biol Med , 26 :892 , 1999
Abstract : Aviram_1999_Free.Radic.Biol.Med_26_892
ESTHER : Aviram_1999_Free.Radic.Biol.Med_26_892
PubMedSearch : Aviram_1999_Free.Radic.Biol.Med_26_892
PubMedID: 10232833

Title : Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase\/arylesterase - Sorenson_1999_Chem.Biol.Interact_119-120_243
Author(s) : Sorenson RC , Aviram M , Bisgaier CL , Billecke S , Hsu C , La Du BN
Ref : Chemico-Biological Interactions , 119-120 :243 , 1999
Abstract : Sorenson_1999_Chem.Biol.Interact_119-120_243
ESTHER : Sorenson_1999_Chem.Biol.Interact_119-120_243
PubMedSearch : Sorenson_1999_Chem.Biol.Interact_119-120_243
PubMedID: 10421458

Title : On the physiological role(s) of the paraoxonases - La Du_1999_Chem.Biol.Interact_119-120_379
Author(s) : La Du BN , Aviram M , Billecke S , Navab M , Primo-Parmo S , Sorenson RC , Standiford TJ
Ref : Chemico-Biological Interactions , 119-120 :379 , 1999
Abstract : La Du_1999_Chem.Biol.Interact_119-120_379
ESTHER : La Du_1999_Chem.Biol.Interact_119-120_379
PubMedSearch : La Du_1999_Chem.Biol.Interact_119-120_379
PubMedID: 10421474

Title : Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans - Haley_1999_Toxicol.Appl.Pharmacol_157_227
Author(s) : Haley RW , Billecke S , La Du BN
Ref : Toxicol Appl Pharmacol , 157 :227 , 1999
Abstract : Haley_1999_Toxicol.Appl.Pharmacol_157_227
ESTHER : Haley_1999_Toxicol.Appl.Pharmacol_157_227
PubMedSearch : Haley_1999_Toxicol.Appl.Pharmacol_157_227
PubMedID: 10373407

Title : Human serum Paraoxonase\/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity - Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214
Author(s) : Sorenson RC , Bisgaier CL , Aviram M , Hsu C , Billecke S , La Du BN
Ref : Arterioscler Thromb Vasc Biol , 19 :2214 , 1999
Abstract : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214
ESTHER : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214
PubMedSearch : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214
PubMedID: 10479665

Title : Increased plasma cholinesterase activity and mivacurium resistance: report of a family -
Author(s) : Naguib M , Gomaa M , Samarkandi AH , Bevan DR , Akkielah AK , Watson C , Billecke S , La Du BN
Ref : Anesthesia & Analgesia , 89 :1579 , 1999
PubMedID: 10589654

Title : Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R - Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617
Author(s) : Aviram M , Billecke S , Sorenson R , Bisgaier C , Newton R , Rosenblat M , Erogul J , Hsu C , Dunlop C , La Du BN
Ref : Arterioscler Thromb Vasc Biol , 18 :1617 , 1998
Abstract : Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617
ESTHER : Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617
PubMedSearch : Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617
PubMedID: 9763535